OneStream Is Maintained at Overweight by Morgan Stanley

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

Here's Why Summit Therapeutics Stock Soared 15% on Friday

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

Preliminary Results for the Year Ended 31 December 2024

Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value

OneStream CEO Thomas Shea to Assume Additional Role of President

BRIEF-OneStream Co-Founder Craig Colby To Transition To Chief Success Officer Effective May 1, 2025 - SEC Filing

Onestream Inc: Co-Founder Craig Colby to Transition to Chief Success Officer Effective May 1, 2025 - SEC Filing

Onestream Inc - Thomas Shea to Assume Role of President - SEC Filing

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

OneStream Announces New ESG Reporting & Planning Solution to Help CFOs Navigate Evolving Reporting Demands

OneStream Is Maintained at Buy by Truist Securities

OneStream price target lowered to $27 from $37 at Truist

OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma

N-able Advances IT Operations and Security Operations with Built-in Vulnerability Management

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

OS Therapies to Host Analyst Day at NYSE on April 7, 2025